510(k) Report

FDA product code · Cardiovascular

Surgical Cardiac Ablation Device, For Treatment Of Atrial Fibrillation

OCMClass IIIPMA required2 decisions since 20110 recalls

2 FDA decisions since 2011. No recall names this code.

Surgical cardiac ablation for the treatment of atrial fibrillation.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, cardiovascular panel

Twenty years of OCM at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · OCM

5in 2025

2011: 12012: 12013: 12014: 22015: 22016: 22018: 12019: 12020: 22021: 12022: 52023: 72024: 22025: 52026 (partial year): 4
2007high 7 (2023) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OCM

Too few OCM 510(k)s in any year since 2007 to give a median.

Recalls per year · OCM

No recall names OCM since 2007.

Adverse event reports per year · OCM

10in 2025

2012: 12015: 12016: 32017: 42018: 52019: 102020: 12021: 62022: 52023: 32024: 162025: 10
2007high 16 (2024) · low 0 (2007)2025

MAUDE reports naming product code OCM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20111—00
20121—01
20131—00
20142—00
20152—01
20162—03
20170—04
20181—05
20191—010
20202—01
20211—06
20225—05
20237—03
20242—016
20255—010
20264—0—
FIG. 1 — OCM by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in OCM? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report